Search Results
Fix price-walking issue by end of 2021, UK tells insurers
Financial Conduct Authority revises timelines for general insurance reforms
Covid-19 UK life claims in 2020 hit £202m
ABI members expect to pay up to £2.5bn, across all lines, in pandemic claims from last year
Steven Findlay takes up Swiss Re CRO role
ABI's former head of prudential regulation returns to industry
Change Solvency II to tackle climate change, insurers say
Direct Line outlines actions to address climate change
"Pandemic Re" solutions may require mandatory purchase of cover
Barriers to creating a pandemic risk pool discussed at ABI's annual conference
Matching adjustment becomes a battleground in UK's Solvency II consultation
Respondents to the UK's consultation on the future of Solvency II have taken starkly opposing positions on the matching adjustment, with some arguing for liberalisation and others for scrapping it. Christopher Cundy reports
Bank of England ignites the debate on UK-EU Solvency II equivalence
The EU is in no rush to grant the UK reciprocal equivalence on Solvency II and has stirred anger by saying it wants to see how far the UK diverges before giving the green light. Paul Walsh assesses the state of play and whether there is any potential for a future agreement
UK motor policyholders are due a £35 Covid-19 windfall, says consumer group
The Association of British Insurers stressed motorists were benefiting from a competitive motor insurance market
Solvency II performed well during Covid-19, but challenges persist
Fitch event panellists discussed Solvency II, Covid-19 and post-pandemic recovery
Genetic testing risks go under the microscope
Do life insurers really face the risk of adverse selection from customers that have taken predictive genetic tests? Academics think not, and insurers and policyholders could indeed benefit from wider use of genetic testing, as Paul Walsh reports